Literature DB >> 25701052

Bone marrow fat is increased in chronic kidney disease by magnetic resonance spectroscopy.

R N Moorthi1, W Fadel2,3, G J Eckert2,3, K Ponsler-Sipes4, S M Moe4,5, C Lin6.   

Abstract

UNLABELLED: In aging, the bone marrow fills with fat and this may lead to higher fracture risk. We show that a bone marrow fat measurement by magnetic resonance spectroscopy (MRS), a newer technique not previously studied in chronic kidney disease (CKD), is useful and reproducible. CKD patients have significantly higher bone marrow fat than healthy adults.
INTRODUCTION: Renal osteodystrophy leads to increased morbidity and mortality in patients with CKD. Traditional bone biopsy histomorphometry is used to study abnormalities in CKD, but the bone marrow, the source of osteoblasts, has not been well characterized in patients with CKD.
METHODS: To determine the repeatability of bone marrow fat fraction assessment by MRS and water-fat imaging (WFI) at four sites in patients with CKD, testing was performed to determine the coefficients of reproducibility and intraclass coefficients (ICCs). We further determined if this noninvasive technique could be used to determine if there are differences in the percent bone marrow fat in patients with CKD compared to matched controls using paired t tests.
RESULTS: The mean age of subjects with CKD was 59.8 ± 7.2 years, and the mean eGFR was 24 ± 8 ml/min. MRS showed good reproducibility at all sites in subjects with CKD and controls, with a coefficient of reproducibilities ranging from 2.4 to 13 %. MRS and WFI assessment of bone marrow fat showed moderate to strong agreement (ICC 0.6-0.7) at the lumbar spine, with poorer agreement at the iliac crest and no agreement at the tibia. The mean percent bone marrow fat at L2-L4 was 13.8 % (95 % CI 8.3-19.7) higher in CKD versus controls (p < 0.05).
CONCLUSIONS: MRS is a useful and reproducible technique to study bone marrow fat in CKD. Patients with CKD have significantly higher bone marrow fat than healthy adults; the relationship with bone changes requires further analyses.

Entities:  

Keywords:  Adipogenesis; Marrow fat; Spectroscopy; Water-fat imaging

Mesh:

Year:  2015        PMID: 25701052      PMCID: PMC4582653          DOI: 10.1007/s00198-015-3064-7

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  31 in total

1.  Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone.

Authors:  M Coco; H Rush
Journal:  Am J Kidney Dis       Date:  2000-12       Impact factor: 8.860

Review 2.  Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications.

Authors:  Mark E Nuttall; Jeffrey M Gimble
Journal:  Curr Opin Pharmacol       Date:  2004-06       Impact factor: 5.547

3.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

4.  Correlation of bone mineral density with the histological findings of renal osteodystrophy in patients on hemodialysis.

Authors:  A Gerakis; D Hadjidakis; E Kokkinakis; T Apostolou; S Raptis; A Billis
Journal:  J Nephrol       Date:  2000 Nov-Dec       Impact factor: 3.902

5.  Quantitative histological studies on age changes in bone.

Authors:  M S Dunnill; J A Anderson; R Whitehead
Journal:  J Pathol Bacteriol       Date:  1967-10

6.  Increased bone fractures among elderly United States hemodialysis patients.

Authors:  John Wagner; Kenar D Jhaveri; Lisa Rosen; Suzanne Sunday; Anna T Mathew; Steven Fishbane
Journal:  Nephrol Dial Transplant       Date:  2013-09-26       Impact factor: 5.992

7.  Increased risk of hip fracture among patients with end-stage renal disease.

Authors:  A M Alem; D J Sherrard; D L Gillen; N S Weiss; S A Beresford; S R Heckbert; C Wong; C Stehman-Breen
Journal:  Kidney Int       Date:  2000-07       Impact factor: 10.612

8.  Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis.

Authors:  J Justesen; K Stenderup; E N Ebbesen; L Mosekilde; T Steiniche; M Kassem
Journal:  Biogerontology       Date:  2001       Impact factor: 4.277

9.  Fractures and vertebral bone mineral density in patients with renal osteodystrophy.

Authors:  B Piraino; T Chen; L Cooperstein; G Segre; J Puschett
Journal:  Clin Nephrol       Date:  1988-08       Impact factor: 0.975

10.  Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: a comparative histomorphometric study.

Authors:  R Burkhardt; G Kettner; W Böhm; M Schmidmeier; R Schlag; B Frisch; B Mallmann; W Eisenmenger; T Gilg
Journal:  Bone       Date:  1987       Impact factor: 4.398

View more
  11 in total

1.  Associations Between Vertebral Marrow Proton Density Fat Fraction and Risk of Prostate Cancer.

Authors:  Shaojun Li; Bo Wang; Wenwen Liang; Qi Chen; Wei Wang; Jiangjun Mei; He Zhang; Qianqian Liu; Mingyuan Yuan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-14       Impact factor: 6.055

2.  Chronic Kidney Disease Is Associated With Greater Bone Marrow Adiposity.

Authors:  Gina N Woods; Susan K Ewing; Sigurdur Sigurdsson; Deborah M Kado; Joachim H Ix; Trisha F Hue; Gudny Eiriksdottir; Kaipin Xu; Vilmundur Gudnason; Thomas F Lang; Eric Vittinghoff; Tamara B Harris; Clifford J Rosen; Xiaojuan Li; Ann V Schwartz
Journal:  J Bone Miner Res       Date:  2018-08-27       Impact factor: 6.741

3.  Cinacalcet attenuated bone loss via inhibiting parathyroid hormone-induced endothelial-to-adipocyte transition in chronic kidney disease rats.

Authors:  Li-Hua Ni; Ri-Ning Tang; Cheng Yuan; Kai-Yun Song; Li-Ting Wang; Xiao-Liang Zhang; Lin-Li Lv; Bin Wang; Min Wu; Tao-Tao Tang; Zuo-Lin Li; Di Yin; Jing-Yuan Cao; Xiao-Chen Wang; Hong Liu; Qiang Chen; Bi-Cheng Liu
Journal:  Ann Transl Med       Date:  2019-07

Review 4.  The Use of Imaging Techniques in Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD)-A Systematic Review.

Authors:  Ana Pimentel; Jordi Bover; Grahame Elder; Martine Cohen-Solal; Pablo Antonio Ureña-Torres
Journal:  Diagnostics (Basel)       Date:  2021-04-26

5.  Knee subchondral bone perfusion and its relationship to marrow fat and trabeculation on multi-parametric MRI and micro-CT in experimental CKD.

Authors:  Chao-Ying Wang; Yu-Juei Hsu; Yi-Jen Peng; Herng-Sheng Lee; Yue-Cune Chang; Chih-Shan Chang; Shih-Wei Chiang; Yi-Chih Hsu; Ming-Huang Lin; Guo-Shu Huang
Journal:  Sci Rep       Date:  2017-06-08       Impact factor: 4.379

Review 6.  Quantitative MRI and spectroscopy of bone marrow.

Authors:  Dimitrios C Karampinos; Stefan Ruschke; Michael Dieckmeyer; Maximilian Diefenbach; Daniela Franz; Alexandra S Gersing; Roland Krug; Thomas Baum
Journal:  J Magn Reson Imaging       Date:  2017-06-01       Impact factor: 4.813

Review 7.  Molecular Interaction of Bone Marrow Adipose Tissue with Energy Metabolism.

Authors:  Karla J Suchacki; William P Cawthorn
Journal:  Curr Mol Biol Rep       Date:  2018-04-28

8.  The effect of vitamin D and zoledronic acid in bone marrow adiposity in kidney transplant patients: A post hoc analysis.

Authors:  Mariel J Hernandez; Luciene M Dos Reis; Igor D Marques; Maria J Araujo; Cesar A M Truyts; Ivone B Oliveira; Fellype C Barreto; Elias David-Neto; Melani R Custodio; Rosa M Moyses; Ezequiel Bellorin-Font; Vanda Jorgetti
Journal:  PLoS One       Date:  2018-05-25       Impact factor: 3.240

9.  CKD Stages, Bone Metabolism Markers, and Cortical Porosity Index: Associations and Mediation Effects Analysis.

Authors:  Yan Xiong; Tongxiang He; Yanan Wang; Weiyin Vivian Liu; Shuang Hu; Yao Zhang; Donglin Wen; Bowen Hou; Yitong Li; Peisen Zhang; Jianyi Liu; Fan He; Xiaoming Li
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-05       Impact factor: 5.555

10.  Bone Marrow Adiposity, Bone Mineral Density and Wnt/β-catenin Pathway Inhibitors Levels in Hemodialysis Patients.

Authors:  Yue-Pei Wang; Nada Khelifi; Cyrille de Halleux; Roth-Visal Ung; France Samson; Claudia Gagnon; Fabrice Mac-Way
Journal:  J Bone Metab       Date:  2022-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.